Item 7.01 Regulation FD Disclosure.

On July 18, 2022, the Registrant held a telephonic conference call to discuss, among other general corporate matters, its financial results for the quarter ended May 31, 2022. The transcript of the conference call is attached as Exhibit 99.1 to this Current Report on Form 8-K.

The information in this Item 7.01, including Exhibit 99.1 is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of Section 18, (and shall not be deemed to be incorporated by reference into the filings of the Registrant under the Securities Act of 1933 or the Exchange Act), except as shall be expressly set forth by specific reference in any such filing. This Current Report will not be deemed an admission as to the materiality of any information contained in this Item 7.01, including Exhibit 99.1.

The information contained in Exhibit 99.1 is summary information that is intended to be considered in the context of the Company's filings with the SEC. The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, although it may do so from time to time as its management believes is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosure.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

99.1 Transcript of Salona Global Medical Device Corporation Conference Call


         held July 18, 2022 at 4:00 p.m. EST.
104      Cover Page Interactive Data File (embedded within the Inline XBRL

document)

© Edgar Online, source Glimpses